[New pharmacological treatment approaches to cardiogenic shock].
Buerke, M
[New pharmacological treatment approaches to cardiogenic shock]. [electronic resource] - Der Internist Dec 2007 - 1442-9 p. digital
Publication Type: Journal Article; Review
0020-9554
10.1007/s00108-007-1979-6 doi
Anti-Inflammatory Agents, Non-Steroidal--adverse effects
Cardiotonic Agents--adverse effects
Catecholamines--adverse effects
Complement C5--antagonists & inhibitors
Complement Inactivating Agents--adverse effects
Humans
Hydrazones--adverse effects
Intra-Aortic Balloon Pumping
Myocardial Infarction--complications
Myocardial Revascularization
Nitric Oxide Synthase--antagonists & inhibitors
Pyridazines--adverse effects
Randomized Controlled Trials as Topic
Shock, Cardiogenic--drug therapy
Simendan
Survival Rate
Vasopressins--adverse effects
[New pharmacological treatment approaches to cardiogenic shock]. [electronic resource] - Der Internist Dec 2007 - 1442-9 p. digital
Publication Type: Journal Article; Review
0020-9554
10.1007/s00108-007-1979-6 doi
Anti-Inflammatory Agents, Non-Steroidal--adverse effects
Cardiotonic Agents--adverse effects
Catecholamines--adverse effects
Complement C5--antagonists & inhibitors
Complement Inactivating Agents--adverse effects
Humans
Hydrazones--adverse effects
Intra-Aortic Balloon Pumping
Myocardial Infarction--complications
Myocardial Revascularization
Nitric Oxide Synthase--antagonists & inhibitors
Pyridazines--adverse effects
Randomized Controlled Trials as Topic
Shock, Cardiogenic--drug therapy
Simendan
Survival Rate
Vasopressins--adverse effects